Azienda Ospedaliero-Universitaria San Luigi Gonzaga

At Azienda Ospedaliero-Universitaria San Luigi Gonzaga, much of the clinical research focuses on neoplasms and blood disorders, with studies spanning non-small cell lung cancer, small cell lung cancer, prostate cancer, renal cell carcinoma, colorectal cancer, head and neck cancer, mesothelioma, gastrointestinal stromal tumor, lymphoma, and myelodysplastic syndrome. These trials are designed to test new treatment approaches, compare them with current standards, and improve outcomes for people with advanced or hard-to-treat cancers.

• Evaluating new cancer therapies for advanced lung cancer and other solid tumors
• Comparing treatment effectiveness in prostate cancer and renal cell carcinoma
• Studying better options for lymphoma and myelodysplastic syndrome

The site’s oncology program reflects a strong interest in both extending survival and refining care for patients with complex malignancies.

Clinical trials here also address respiratory tract diseases and selected rare conditions, including cystic fibrosis and systemic sclerosis-associated interstitial lung disease. Researchers are exploring ways to improve lung function, reduce disease burden, and identify more effective treatment options for patients with chronic and uncommon pulmonary disorders.

• Testing therapies aimed at improving outcomes in cystic fibrosis
• Assessing treatment benefits for systemic sclerosis-associated interstitial lung disease
• Supporting research into better management of chronic lung disease

This mix of studies shows a commitment to both common respiratory illness and rare, high-need disease areas.

The site is active in research on inherited and acquired blood conditions, including alpha-thalassemia, beta-thalassemia, and anemia linked to myelodysplastic syndrome. These trials aim to improve red blood cell production, reduce transfusion needs, and support safer, more effective care for patients with chronic hematologic disease.

• Exploring new options for thalassemia in adults, adolescents, and children
• Evaluating treatments for anemia in myelodysplastic syndrome
• Advancing care for transfusion-dependent blood disorders

These studies highlight a strong focus on inherited hemoglobin disorders and supportive care for patients living with long-term blood diseases.

Research at the Department of SCDU Oncologia Medica, AOU San Luigi Orbassano extends beyond cancer into urgent care settings, including acute myocardial infarction and critical illness. The trials are aimed at improving early intervention, preventing serious complications, and strengthening emergency treatment strategies for high-risk patients.

• Studying ways to reduce complications in acute myocardial infarction
• Testing approaches to prevent collapse during tracheal intubation
• Improving emergency response in critically ill adults

These investigations support better decision-making in time-sensitive cardiovascular and intensive care situations.

The site also includes studies in type 2 diabetes mellitus and skin and connective tissue diseases, reflecting interest in chronic conditions that require long-term management. In parallel, trials in systemic sclerosis are examining whether treatment can slow lung decline and improve overall disease control.

• Evaluating participant-centered trial approaches in type 2 diabetes mellitus
• Testing therapies for systemic sclerosis with lung involvement
• Exploring better long-term management of chronic metabolic and autoimmune disease

These studies aim to make treatment more effective and more practical for people managing ongoing complex illnesses.